The discussion of the relationship between cardiopulmonary bypass and postoperative thyroid function changes in pediatric congenital heart disease,and the analysis of oral thyroid hormone therapy and cardiac prognosis

Abstract

Objective

This study aims to investigate the relationship between CPB factors and changes in TH levels in postoperative patients and the effect of oral levothyroxine sodium tablets on outcomes in patients with postoperative TF abnormalities.

Methods

Select patients who underwent CHD surgery between September 2017 and September 2023 and were aged 13 years or younger. The relationship between CPB and postoperative TF changes and the influencing factors were analyzed. In addition, patients with different diseases and ages were divided into the medication group and the non-medication group. The primary outcome was postoperative ejection fraction (EF), and the secondary outcomes were PICU hospitalization days and total hospital cost.

Results

Seven hundred 53 patients were included. The longer the CPB time and ACC time, the lower the postoperative triiodothyronine (T3) and thyroxin (T4) levels (p < 0.001 and p < 0.001). The longer the CPB time, the more pronounced the postoperative T3 level abnormality (p < 0.001). The longer the CPB time, ACC time, and DHCA time, the more pronounced the postoperative T4 level abnormalities (p < 0.001 and p < 0.001 and p = 0.046). The postoperative EF of patients in the medication group was slightly higher than that of the non-medication group, and the EF before discharge was significantly higher than that of the non-medication group (p = 0.021, p = 0.015, and p = 0.024). Postoperative PICU days in the medication group [3.0 (2.0,7.0) versus4.0 (2.0,10.0), p = 0.020] were shorter than the non-medication group, and the proportion of ≤ 5 days was more [154 (66.1%) versus304 (58.5%), p = 0.047]. The total hospitalization cost was slightly lower in the medication group (p < 0.05).

Conclusion

The duration of CPB, ACC, and DHCA in the open surgery process for CHD affects patients’ thyroid function in the postoperative period. In our study, we found that oral levothyroxine sodium tablets are beneficial to the children’s postoperative recovery.

Keywords

thyroid hormone congenital heart disease cardiopulmonary bypass ejection fraction pediatric intensive care unit

Get full access to this article

View all access options for this article.

References

Liu

Huang

, et al. Euthyroid sick syndrome and nutritional status are correlated with hyposelenemia in hemodialysis patients. Int J Artif Organs 2011; 34(7): 577–583.

Wang

. Euthyroid sick syndrome in children with diabetic ketoacidosis. Saudi Med J 2015; 36(2): 243–247.

Priest

Slee

Olson

, et al. Triiodothyronine supplementation and cytokines during cardiopulmonary bypass in infants and children. J Thorac Cardiovasc Surg 2012; 144(4): 938–943.

Wartofsky

Burman

. Alterations in thyroid function in patients with systemic illness: the euthyroid sick syndrome. Endocr Rev 1982; 3(2): 164–217.

Ross

Petros

. The sick euthyroid syndrome in paediatric cardiac surgery patients. Intensive Care Med 2001; 27(7): 1124–1132.

Plumpton

Haas

. Identifying infants at risk of marked thyroid suppression post-cardiopulmonary bypass. Intensive Care Med 2005; 31(4): 581–587.

Marwali

Boom

Sakidjan

, et al. Oral triiodothyronine normalizes triiodothyronine levels after surgery for pediatric congenital heart disease. Pediatr Crit Care Med 2013; 14(7): 701–708.

Utiger

. Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat? N Engl J Med 1995; 333(23): 1562–1563.

Gil-Gomez

Blasco-Alonso

Castillo-Martin

, et al. Prognostic indicators after cardiac surgery in children and their relationship with the oxidative stress response. Rev Esp Anestesiol Reanim 2016; 63(1): 3–12.

10.

Bapat

Allen

Young

, et al. Survival and quality of life after cardiac surgery complicated by prolonged intensive care. J Card Surg 2005; 20(3): 212–217.

11.

Plikat

Langgartner

Buettner

, et al. Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism 2007; 56(2): 239–244.

12.

Jabbar

Pingitore

Pearce

, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol 2017; 14(1): 39–55.

13.

Bartkowski

Wojtalik

Korman

, et al. Thyroid hormones levels in infants during and after cardiopulmonary bypass with ultrafiltration. Eur J Cardio Thorac Surg 2002; 22(6): 879–884.

14.

Ririe

Butterworth

Hines

, et al.

Effects of cardiopulmonary bypass and deep hypothermic circulatory arrest on the thyroid axis during and after repair of congenital heart defects: preservation by deep hypothermia?

Anesth Analg 1998; 87(3): 543–548.

15.

Kong

Zhang

Chen

, et al. Cytokine changes after cardiopulmonary bypass in pediatric congenital heart disease. Pediatric Emergency medicine in China J 2022; 29(05): 359–362.

16.

Marwali

Boom

Budiwardhana

, et al. Oral triiodothyronine for infants and children undergoing cardiopulmonary bypass. Ann Thorac Surg 2017; 104(2): 688–695.

17.

Portman

Slee

Olson

, et al. Triiodothyronine supplementation in infants and children undergoing cardiopulmonary bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis. Circulation 2010; 122(11 Suppl): S224.

18.

Mackie

Booth

Newburger

, et al. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg 2005; 130(3): 810–816.

19.

Behrman

Kliegman

Jenson

. Nelson textbook of pediatrics. 17th ed. Philadelphia: Saunders, 2004.

20.

Yang

. Pediatric cardiology. 4th ed. Beijing: People's Medical Publishing House, 2012.

21.

Talwar

Bhoje

Khadagawat

, et al. Oral thyroxin supplementation in infants undergoing cardiac surgery: a double-blind placebo-controlled randomized clinical trial. J Thorac Cardiovasc Surg 2018; 156(3): 1209–1217.